Dyax DX-88 Submission Likely Postponed For Additional Dosing Study

FDA seeks a subcutaneous dose-ranging study on the recombinant protein to treat hereditary angioedema.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet